Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$1.88 - $3.35 $146,880 - $261,728
-78,128 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$1.66 - $4.16 $129,692 - $325,012
78,128 New
78,128 $139,000
Q3 2018

Nov 13, 2018

SELL
$3.75 - $4.65 $532,125 - $659,835
-141,900 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$3.7 - $5.8 $525,030 - $823,020
141,900 New
141,900 $525,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $730M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.